Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000665385 | SCV000789499 | uncertain significance | Deficiency of steroid 11-beta-monooxygenase | 2017-02-03 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002271551 | SCV002555869 | likely pathogenic | Congenital adrenal hyperplasia | 2022-06-14 | criteria provided, single submitter | clinical testing | Variant summary: CYP11B1 c.235T>A (p.Phe79Ile) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 250986 control chromosomes (gnomAD). c.235T>A has been reported in the literature in at least one individual affected with Steroid 11 -hydroxylase (CYP11B1) deficiency (Reisch_2013). These data indicate that the variant is very likely to be associated with disease. At least one functional study reports experimental evidence evaluating an impact on protein function and this variant effect results in less than 10% of normal activity in transfected cells (Reisch_2013). One ClinVar submitter (evaluation after 2014) cites the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as likely pathogenic. |
Baylor Genetics | RCV000665385 | SCV004215362 | likely pathogenic | Deficiency of steroid 11-beta-monooxygenase | 2023-04-11 | criteria provided, single submitter | clinical testing |